University Hospital Ghent
Ghent, 9000, Belgium
Location status: Recruiting
NCT Number: NCT06175832
P-CCROSS is a randomized, prospective monocentric phase 4 study with a crossover study design. The aim of the study is to compare patient satisfaction (by means of questionnaires) and treatment compliance with IVF treatment with CFA (corifollitropin alfa) and PPOS (Progestin-Primed Ovarian Stimulation) versus conventional IVF treatment with a recombinant FSH/GnRH antagonist. The study will also compare patients undergoing elective fertility preservation versus PGT-A (pre-implantation genetic testing for aneuploidy) patients.The study will have a crossover design so that patients will receive both forms of treatment. The investigators will also compare the endocrine profile and ovarian response of CFA/PPOS versus rFSH/GnRH ovarian stimulation cycles.
Interested in participating?
Request Info18 year–40 year
Female
Interventional
Phase 4
Ghent, 9000, Belgium
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Prescreening: Clarification: Pre-screening might be performed to identify women with AFC > 5 and AMH > 1.1 ng/ml (Bologna criteria, AFC and AMH values are valid for one year).
Inclusion criteria
for:
Inclusion criteria
for both groups:
Exclusion criteria
Single injection
Multiple injections
Multiple injections
Double injection
Oral tablet
Time frame: Six months
Comparison of CFA / PPOS stimulation versus conventional rFSH / GnRH antagonist ovarian stimulation cycles with respect to mean treatment-related quality of life and patient satisfaction. Treatment-related quality of life and patient satisfaction retrieved from the second questionnaire (Q2), which is completed at the end of each stimulation cycle; after the agonist trigger and before the oocyte retrieval.Q2 is a combination of the treatment module of the validated FertiQoL questionnaire and the EFESO questionnaire. This questionnaire will assess the environment and tolerability of the fertility treatment.
Contact information is provided by the study sponsor or research team.
Dominic Stoop, Prof. dr.
CONTACT
Kathleen Wijnant, Msc
CONTACT
University Hospital, Ghent
Other
PPOS and CFA for Elective Freeze-all Ovarian Stimulation Cycles: a Prospective Cross-over Study
Acronym: P-CCROSS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06839274
OVARIAN STIMULATION
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
View Trial DetailsNCT06572930
OVARIAN STIMULATION
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
View Trial DetailsNCT07515118
Artificial Intelligence, Genital Diseases
Sabadell, Barcelona, Spain
View Trial DetailsNCT06732843
OVARIAN STIMULATION, Telomere Length
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
View Trial Details